Delayed administration of D-Ala2-D-Leu5-enkephalin, a delta-opioid receptor agonist, improves survival in a rat model of sepsis.

The Tohoku journal of experimental medicine

Volumn 224, Issue 1, 2011, Pages 69-76

  Tang, Cheng Wu ^a   Feng, Wen Ming ^b   Du, Hui Min ^b   Bao, Ying ^b   Zhu, Ming ^b  

^a HUZHOU UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; ENKEPHALIN[2 ALANINE 5 LEUCINE]; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG EFFECT; DRUG POTENTIATION; HUMAN; IMMUNOLOGY; MALE; METABOLISM; PERITONEUM MACROPHAGE; RAT; SEPSIS; SPRAGUE DAWLEY RAT; SURVIVAL RATE;

ANIMALS; DISEASE MODELS, ANIMAL; ENKEPHALIN, LEUCINE-2-ALANINE; HMGB1 PROTEIN; HUMANS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; SEPSIS; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80051598392     PISSN: None     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.224.69     Document Type: Article

References (0)